| 000 | 01539 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516090634.0 | ||
| 264 | 0 | _c20120814 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1756-8927 | ||
| 024 | 7 |
_a10.4155/fmc.12.29 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMusumeci, Francesca | |
| 245 | 0 | 0 |
_aAn update on dual Src/Abl inhibitors. _h[electronic resource] |
| 260 |
_bFuture medicinal chemistry _cApr 2012 |
||
| 300 |
_a799-822 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAniline Compounds _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 |
_aBenzodioxoles _xchemistry |
| 650 | 0 | 4 | _aDasatinib |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aNitriles _xchemistry |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-abl _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrimidines _xchemistry |
| 650 | 0 | 4 |
_aQuinazolines _xchemistry |
| 650 | 0 | 4 |
_aQuinolines _xchemistry |
| 650 | 0 | 4 |
_aThiazoles _xchemistry |
| 650 | 0 | 4 |
_asrc-Family Kinases _xantagonists & inhibitors |
| 700 | 1 | _aSchenone, Silvia | |
| 700 | 1 | _aBrullo, Chiara | |
| 700 | 1 | _aBotta, Maurizio | |
| 773 | 0 |
_tFuture medicinal chemistry _gvol. 4 _gno. 6 _gp. 799-822 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4155/fmc.12.29 _zAvailable from publisher's website |
| 999 |
_c21728879 _d21728879 |
||